Hemispherx BioPharma, Inc Stock price Nyse
Equities
US42366C3016
Biotechnology & Medical Research
Financials (USD)
Sales 2023 * | 157K | Sales 2024 * | 70K | Capitalization | 21.64M |
---|---|---|---|---|---|
Net income 2023 * | -22M | Net income 2024 * | -27M | EV / Sales 2023 * | 138 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 309 x |
P/E ratio 2023 * |
-0.98
x | P/E ratio 2024 * |
-0.98
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 91.31% |
Latest transcript on Hemispherx BioPharma, Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Equels
CEO | Chief Executive Officer | 72 | 08-11-16 |
Robert Dickey
DFI | Director of Finance/CFO | 68 | 22-04-03 |
Chief Tech/Sci/R&D Officer | - | 22-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy K. Bryan
BRD | Director/Board Member | 66 | 23-03-27 |
Chairman | 88 | 98-06-30 | |
Thomas Equels
CEO | Chief Executive Officer | 72 | 08-11-16 |
1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |